Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Xenon Pharmaceuticals Inc. (XENE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Quarterly results
Docs: "Xenon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update Last patient enrolled in XEN1101 Phase 2 X-NOVA clinical trial in major depressive disorder with topline data expected in late November to mid-December Continued progress across all XEN1101 Phase 3 epilepsy programs including in X-TOLE2 and X-TOLE3 clinical trials in focal onset seizures and X-ACKT in primary generalized tonic-clonic seizures Xenon to host XEN1101 MDD Webinar in mid-September to discuss Kv modulation in MDD, the X-NOVA clinical trial and the broader MDD landscape Conference call at 4:30 pm ET today"
05/09/2023 8-K Quarterly results
Docs: "Xenon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update XEN1101 Phase 3 epilepsy program continues to make significant progress across all ongoing clinical trials including the recent initiation of X-TOLE3 in addition to the ongoing X-TOLE2 and X-ACKT Phase 3 clinical trials Anticipate last patient to be screened next month in XEN1101 Phase 2 X-NOVA clinical trial in major depressive disorder with topline data expected in fourth quarter Conference call at 4:30 pm ET today"
03/01/2023 8-K Quarterly results
Docs: "Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update XEN1101 Phase 3 epilepsy program continues to advance in focal onset seizures and primary generalized tonic clonic seizures Topline data from XEN1101 Phase 2 X-NOVA clinical trial in major depressive disorder expected in third quarter Conference call at 4:30 pm ET today"
11/08/2022 8-K Quarterly results
08/09/2022 8-K Quarterly results
Docs: "Xenon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update Xenon remains on track to initiate the XEN1101 Phase 3 program within second half of this year"
05/10/2022 8-K Quarterly results
11/10/2021 8-K Quarterly results
Docs: "Xenon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update XEN1101 X-TOLE Presentations Scheduled at AES 2021 with Planning Underway for Phase 3 Initiation in 2022 Conference Call at 4:30 pm ET Today"
08/11/2021 8-K Quarterly results
05/11/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "Xenon Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update Experienced Biotech Executive, Patrick Machado, Joins Xenon’s Board of Directors Conference Call at 4:30 pm ET Today"
08/06/2020 8-K Quarterly results
05/21/2020 8-K Quarterly results
Docs: "Xenon Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update Progress Reported in Both Proprietary and Partnered Neurology Clinical Programs"
11/05/2019 8-K Quarterly results
08/06/2019 8-K Quarterly results
05/07/2019 8-K Quarterly results
Docs: "Xenon Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update Company Reports Advancements in Neurology-Focused Pipeline and Anticipates Multiple Products in Phase 2 or Later Stage Development this Year"
11/06/2018 8-K Quarterly results
Docs: "Xenon Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update Robust, Novel Pipeline of Neurology Candidates Advancing in Clinical Development Conference Call at 4:30 pm ET Today"
08/07/2018 8-K Quarterly results
Docs: "Xenon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update Novel Epilepsy Product Candidates – XEN1101 and XEN901 – Continue to Advance in the Clinic"
11/07/2017 8-K Quarterly results
Docs: "Xenon Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate Update"
08/03/2017 8-K Quarterly results
05/09/2017 8-K Form 8-K - Current report
11/03/2016 8-K Quarterly results
Docs: "Xenon Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update"
08/03/2016 8-K Form 8-K - Current report
05/10/2016 8-K Form 8-K - Current report
11/10/2015 8-K Quarterly results
Docs: "Xenon Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Corporate Update"
08/10/2015 8-K Quarterly results
Docs: "Xenon Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Corporate Update"
05/12/2015 8-K Quarterly results
Docs: "Xenon Pharmaceuticals Reports First Quarter 2015 Financial Results and Provides Corporate Update"
12/15/2014 8-K Quarterly results
Docs: "Xenon Pharmaceuticals Reports Third Quarter 2014 Financial Results"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy